Potent retinoid synergists with a diphenylamine skeleton

Biological and Pharmaceutical Bulletin

Volumn 21, Issue 5, 1998, Pages 544-546

  Ohta, Kiminori ^a   Tsuji, Motonori ^a   Kawachi, Emiko ^a   Fukasawa, Hiroshi ^a   Hashimoto, Yuichi ^a   Shudo, Koichi ^a   Kagechika, Hiroyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cell differentiation; Retinoic acid; Retinoid; Synergist

Indexed keywords

4 [N (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)AMINO]BENZOIC ACID; DIPHENYLAMINE DERIVATIVE; RETINOIC ACID; RETINOID; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; DRUG POTENTIATION; HUMAN; HUMAN CELL; PLEIOTROPY;

EID: 0031807177     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.21.544     Document Type: Article

References (14)

1. Sporn M.B., Roberts A. B., Goodman D. S. (Eds.), The Retinoids, 2nd ed., Raven Press, New York (1994).
2. Bollag W., Holdener E. E. Ann. Oncol., 3, 513-526 (1992); Hill D. L., Grubbs C. J. Ann. Rev. Nutr., 12, 161-181 (1992); Chomienne C., Fenaux P., Degos L. FASEB J, 10, 1025-1030 (1996).
3. Bollag W., Holdener E. E. Ann. Oncol., 3, 513-526 (1992); Hill D. L., Grubbs C. J. Ann. Rev. Nutr., 12, 161-181 (1992); Chomienne C., Fenaux P., Degos L. FASEB J, 10, 1025-1030 (1996).
4. Bollag W., Holdener E. E. Ann. Oncol., 3, 513-526 (1992); Hill D. L., Grubbs C. J. Ann. Rev. Nutr., 12, 161-181 (1992); Chomienne C., Fenaux P., Degos L. FASEB J, 10, 1025-1030 (1996).
5. Chambon P., FASEB J., 10, 940-954 (1996).
6. Hashimoto Y., Kagechika H., Shudo K. Biochem. Biophys. Res. Commun., 166, 1300-1307 (1990).
7. Umemiya H., Fukasawa H., Ebisawa M., Eyrolles L., Kawachi E., Eisenmann G., Gronemeyer H., Hashimoto Y., Shudo K., Kagechika H., J. Med. Chem., 40, 4222-4234 (1997), and references cited therein.
8. Gottardis M. M., Bischoff E. D., Shirley M. A., Wagoner M. A., Lamph W. W., Heyman R. A., Cancer Res., 56, 5566-5570 (1996).
9. Wolfe J. P., Buchwald S. L., J. Org. Chem., 62, 1264-1267 (1997); Marcoux J.-F., Wagaw S., Buchwald S. L., J. Org. Chem., 62, 1568-1569 (1997).
10. Wolfe J. P., Buchwald S. L., J. Org. Chem., 62, 1264-1267 (1997); Marcoux J.-F., Wagaw S., Buchwald S. L., J. Org. Chem., 62, 1568-1569 (1997).
11. Compound DA023 (11) having an N-cyclopropyl group was prepared by two-step coupling reactions of cyclopropylamine with ethyl p-iodobenzoate (56 %) and then with 6-bromo-1,2,3,4-tetrahydro-1,1,4,4-tetramethylnaphthalene (20 %), followed by ester hydrolysis (35 %).
12. Collins S. J., Gallo R. C., Gallagher R. E., Nature (London), 270, 347 (1977); Koeffler H. P., Blood, 62, 709 (1983).
13. Collins S. J., Gallo R. C., Gallagher R. E., Nature (London), 270, 347 (1977); Koeffler H. P., Blood, 62, 709 (1983).
14. Collins S.J, Ruscetti F.W., Gallagher R.E., Gallo R.C., J. Exp. Med., 149, 969 (1979).